We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

ASMS Introduces… An Overview of What’s New for 2019
Industry Insight

The 67th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics is currently in full swing in Atlanta, Georgia. Bringing together over 6,500 scientists from across the globe, companies working in the mass spectrometry field also take this opportunity to share their latest developments and innovations. Here we will take a look at some of the release highlights for 2019.

Read More

Why Should Antibodies Be Manufactured Recombinantly?
Industry Insight

Given that bad antibodies are likely to blame for a significant proportion of the reproducibility crisis in science, any efforts to reduce batch-to-batch variability are more than welcome. One company with a plan to help in this area is “Absolute Antibody”, who believe that recombinant antibodies are the way forward. To learn more about making antibodies with recombinant technology, we spoke to Ian Wilkinson, PhD, Chief Scientific Officer.

Read More

Exosomes: Isolation and Investigation
Industry Insight

Exosomes are small vesicles of 30 to 150 nm. To investigate their function there is a need to optimize and standardize the methods employed to isolate exosomes. However, before exploring the different methods, it is worth explaining what makes exosomes so interesting…

Read More

A Microfluidic Approach to Gene Delivery in GMCT
Industry Insight

The development of GMCTs has been halted by issues surrounding the most critical step in their creation, the introduction of new genetic material. Recently, Indee Labs announced the publication of a study illustrating the efficacy of it's GMCT development and manufacturing technology. We spoke with Indee Labs' CEO Ryan Pawell to learn more about the technology and its applications.

Read More

Bringing Balance to the Lab
Industry Insight

It is an undeniable fact that the success of most experiments in R&D and analytical labs hinges on reliable weighing. It should go without say that dependable lab balances are critical. Often little focus is given to such a vital cog in the machine.

Read More

Entering the Antibody Lottery: Tips for Avoiding Dubious Sources
Industry Insight

Having reliable antibodies can make or break your assay. However, sourcing the right antibody for the job can sometimes feel like you’re entering the lottery: there are so many on the market, and often they just don’t live up to what was promised. To learn more about antibody validation and its importance, we got in touch with Anthony Couvillon, PhD, Scientific Marketing Project Manager at Cell Signaling Technology.

Read More

Flow Cytometry in the Clinic
Industry Insight

Flow cytometry is a technique used to count and analyze the size, shape and properties of individual cells. Not just a valuable research tool, flow cytometry is also finding its stride in several clinical areas. Following BD Biosciences’ launch of a new sample preparation instrument, we spoke to Stephen Gunstream, VP and general manager, to get his insights on the role of flow cytometry in the clinic.

Read More

Single-cell DNA Analysis: Driving Dynamic Changes in the Treatment of Cancer
Industry Insight

We recently spoke to Charlie Silver, CEO and Co-Founder of Mission Bio, to learn more about how they are helping researchers profile mutational heterogeneity at the single-cell level.

Read More

Releasing the Handbrake on Exosome Applications
Industry Insight

Despite the great excitement about exosomes and their huge diagnostic and therapeutic potential, the technology needed to advance this work is lacking. We spoke to Jim West, CEO of Clara Biotech, who tells us how his team is working to fill that gap.

Read More

Automated Microfluidic Systems for Gene Editing
Industry Insight

Recently, Oxford Genetics and Sphere Fluidics announced a multi-partner collaboration to expedite the development of automated microfluidic systems for rapid and high-throughput gene editing in mammalian cells. We spoke with Emily Leproust, PhD, CEO of Twist Biosciences, and other collaborators from the partnership to discuss the background of this announcement and the need for automated systems in gene editing.

Read More

 
Advertisement